Glaxosmithkline | GSK - Biaya Penjualan

Harga Saham
51.74
Perubahan Harian
-7.38 -12.48%
Bulanan
-12.69%
Tahunan
31.86%
Q1 Perkiraan
52.28




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.55B 757M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bausch Health Companies USD 1.03B 284M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.47B 461.37M 2025-12
J&J USD 7.97B 689M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Zoetis USD 743M 60M 2025-12